| abstract |
The present invention relates to: (a) a compound of formula Ia (R1, R4, R5, R6, n and A are as defined herein) useful as a dopamine-beta -hydroxylase inhibitor, Acceptable salts or solvates; (b) a pharmaceutical composition comprising such a compound, salt or solvate; (c) the use of such compounds, salts or solvates in therapy; (d) therapeutic methods of treating such compounds, salts or solvates; And (e) processes and intermediates useful in the synthesis of such compounds. |